The treatment of cerebral palsy: What we know, what we don't know.
M. Goldstein. J Pediatr, 145 (2 Suppl):
S42--S46(August 2004)
Abstract
The treatment of cerebral palsy is directed at repair of the injured brain and at the management of the impairments and disabilities resulting from developmental brain injury. Currently, there are no clinically meaningful interventions that can successfully repair existing damage to the brain areas that control muscle coordination and movement. However, several interventions are available to diminish the degree of impairment (eg, muscle spasticity) and to increase participation in activities of daily living. Data on treatment compatible with evidence-based medicine are now being collected.
%0 Journal Article
%1 Goldstein2004
%A Goldstein, Murray
%D 2004
%J J Pediatr
%K Activities of Daily Living; Baclofen; Botulinum Toxin Type A; Brain; Cerebral Palsy; Complementary Therapies; Dopamine; Evidence-Based Medicine; Humans; Levodopa; Muscle Relaxants, Central; Spasticity; Neuromuscular Agents; Neuronal Plasticity; Physical Therapy Modalities; Rhizotomy; Stem Cell Transplantation; Treatment Outcome
%N 2 Suppl
%P S42--S46
%T The treatment of cerebral palsy: What we know, what we don't know.
%V 145
%X The treatment of cerebral palsy is directed at repair of the injured brain and at the management of the impairments and disabilities resulting from developmental brain injury. Currently, there are no clinically meaningful interventions that can successfully repair existing damage to the brain areas that control muscle coordination and movement. However, several interventions are available to diminish the degree of impairment (eg, muscle spasticity) and to increase participation in activities of daily living. Data on treatment compatible with evidence-based medicine are now being collected.
@article{Goldstein2004,
abstract = {The treatment of cerebral palsy is directed at repair of the injured brain and at the management of the impairments and disabilities resulting from developmental brain injury. Currently, there are no clinically meaningful interventions that can successfully repair existing damage to the brain areas that control muscle coordination and movement. However, several interventions are available to diminish the degree of impairment (eg, muscle spasticity) and to increase participation in activities of daily living. Data on treatment compatible with evidence-based medicine are now being collected.},
added-at = {2014-07-19T19:33:54.000+0200},
author = {Goldstein, Murray},
biburl = {https://www.bibsonomy.org/bibtex/22befeb804f2f0373f9f23b9db87e08c6/ar0berts},
groups = {public},
interhash = {caf2f751c1fc383b2a4be67d482ad430},
intrahash = {2befeb804f2f0373f9f23b9db87e08c6},
journal = {J Pediatr},
keywords = {Activities of Daily Living; Baclofen; Botulinum Toxin Type A; Brain; Cerebral Palsy; Complementary Therapies; Dopamine; Evidence-Based Medicine; Humans; Levodopa; Muscle Relaxants, Central; Spasticity; Neuromuscular Agents; Neuronal Plasticity; Physical Therapy Modalities; Rhizotomy; Stem Cell Transplantation; Treatment Outcome},
month = Aug,
number = {2 Suppl},
pages = {S42--S46},
pii = {S0022347604004184},
pmid = {15292887},
timestamp = {2014-07-19T19:33:54.000+0200},
title = {The treatment of cerebral palsy: What we know, what we don't know.},
username = {ar0berts},
volume = 145,
year = 2004
}